Efficacy and safety of SY-3505, a third-generation ALK TKI, in ALK-positive advanced nonsmall cell lung cancer: Results from a phase I/II, multi-center studyYuankai Shi,Xingsheng Hu,Xingya Li,Yongsheng Li,Ke Wang,Pingli Wang,Liyan Jiang,Shucai Zhang,Xiangjiao Meng,Huijuan Wang,Xiaorong Dong, Runxiang Yang,Yongzhong Luo,Qi Mei,Yinghui SunJOURNAL OF CLINICAL ONCOLOGY（2023）引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
